N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-toluidine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 125979 |
| SCHEMBL ID | 127387 |
| MeSH ID | M0134026 |
| Synonym |
|---|
| n-ethyl-n-(2-hydroxy-3-sulfopropyl)-m-toluidine |
| 3-[ethyl(3-methylphenyl)amino]-2-hydroxypropane-1-sulfonic acid |
| 96497-76-6 |
| n-ethyl-n-(2-hydroxy-3-sulfopropyl)-3-toluidine |
| 1-propanesulfonic acid, 3-(ethyl(3-methylphenyl)amino)2-hydroxy- |
| SCHEMBL127387 |
| DTXSID30868670 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.25) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||